Author:
Kleniewska Paulina,Kopa-Stojak Paulina Natalia,Hoffmann Arkadiusz,Pawliczak Rafał
Abstract
AbstractThe aim of this study was to investigate the influence of Bacteroides vulgatus (BV), Clostridium perfringens (CP), Parabacteroides distasonis (PD) and Ruminococcus albus (RA) lysates on secretion of selected cytokines by PBMC, MDM and HT-29 cells, as well as to determine the potential mechanisms of their action in the development of asthma. Enzyme-linked immunosorbent assays were used to analyze the effect of BV, CP, PD and RA lysates on the secretion of IL-1β, IL-6, IL-10 and TNF-α by human PBMC, MDM and HT-29 cells. BV and CP lysates significantly lowered IL-1β secretion by MDM vs. control (p < 0.05 and p < 0.001 respectively) but only at a dose of 400 µg lysate. The secretions of IL-6 by PBMC and MDM were elevated significantly above control values (p < 0.05) after administration of CP and PD lysates. BV, CP and PD lysates (100 µg) significantly increased IL-10 secretion by PBMC vs. control (p < 0.05). CP, PD and RA lysates (400 µg) significantly increased IL-10 secretion by MDM vs. control (p < 0.001). BV lysate (400 µg) also significantly increased IL-10 secretion by MDM as compared to control (p < 0.05). In PBMC and MDM, the production levels of the anti-inflammatory cytokine were increased by all the bacterial lysates used in a dose-dependent manner.
Funder
Polpharma Scientific Foundation
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Akkoc, T., O’Mahony, L., Ferstl, R., Akdis, C. & Akkoc, T. Mouse models of asthma: Characteristics, limitations and future perspectives on clinical translation. In Cell Biology and Translational Medicine Vol. 15 (ed. Turksen, K.) 119–33 (Springer International Publishing, 2021).
2. Centers for Disease Control and Prevention. Vital Signs: Asthma Prevalence, Disease Characteristics, and Self-Management Education --- United States, 2001--2009 [Internet], [cited 2022 Nov 29] (2011).
3. Holgate, S. T. et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J. Allergy Clin. Immunol. 117(3), 496–506 (2006).
4. Our World in Data. Asthma prevalence, 1990 to 2019 [Internet] (2022).
5. The Global Asthma Report 2022. The international journal of tuberculosis and lung disease. Int. J. Tuberc. Lung Dis. 26(1), 1–104 (2022).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献